NetworkNewsBreaks – Pressure BioSciences Inc.’
Post# of 1354
(Total Views: 210)
Posted On: 07/18/2019 2:51:15 PM
NetworkNewsBreaks – Pressure BioSciences Inc.’s (PBIO) Flagship Barocycler 2320EXTREME Featured at International Conference in China
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, this morning announced that its flagship Barocycler 2320EXTREME was prominently featured at a three-day, internationally-attended scientific conference held at the elite Westlake University in Hangzhou, China. Professor Tiannan Guo, MD., PhD, a well-known protein research scientist, was one of the primary conference organizers. Professor Guo’s Westlake laboratory was named a PBI Center of Excellence in 2017. “Many of the studies on cancer biopsy tissues performed at Westlake and in the laboratories of our collaboration partners rely critically on PBI’s PCT platform to rapidly and reproducibly extract high quality proteins from tumor tissues for analysis by mass spectrometry,” Professor Guo stated in the news release. “It is hoped that such activities will eventually result in the discovery of new biomarkers of disease and possibly even new drug targets.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, this morning announced that its flagship Barocycler 2320EXTREME was prominently featured at a three-day, internationally-attended scientific conference held at the elite Westlake University in Hangzhou, China. Professor Tiannan Guo, MD., PhD, a well-known protein research scientist, was one of the primary conference organizers. Professor Guo’s Westlake laboratory was named a PBI Center of Excellence in 2017. “Many of the studies on cancer biopsy tissues performed at Westlake and in the laboratories of our collaboration partners rely critically on PBI’s PCT platform to rapidly and reproducibly extract high quality proteins from tumor tissues for analysis by mass spectrometry,” Professor Guo stated in the news release. “It is hoped that such activities will eventually result in the discovery of new biomarkers of disease and possibly even new drug targets.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Pressure Biosciences (PBIO) Stock Research Links
Scroll down for more posts ▼